Annual Cash & Cash Equivalents
$15.69 M
+$5.36 M+51.89%
December 31, 2023
Summary
- As of February 8, 2025, TTOO annual cash & cash equivalents is $15.69 million, with the most recent change of +$5.36 million (+51.89%) on December 31, 2023.
- During the last 3 years, TTOO annual cash & cash equivalents has fallen by -$1.10 million (-6.57%).
- TTOO annual cash & cash equivalents is now -98.04% below its all-time high of $801.00 million, reached on December 31, 2013.
Performance
TTOO Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$2.08 M
-$2.16 M-50.94%
September 30, 2024
Summary
- As of February 8, 2025, TTOO quarterly cash and cash equivalents is $2.08 million, with the most recent change of -$2.16 million (-50.94%) on September 30, 2024.
- Over the past year, TTOO quarterly cash and cash equivalents has dropped by -$13.61 million (-86.72%).
- TTOO quarterly cash and cash equivalents is now -97.24% below its all-time high of $75.59 million, reached on September 30, 2014.
Performance
TTOO Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TTOO Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +51.9% | -86.7% |
| 3 y3 years | -6.6% | -90.5% |
| 5 y5 years | -69.1% | -87.2% |
TTOO Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.5% | +51.9% | -91.4% | at low |
| 5 y | 5-year | -29.5% | +51.9% | -94.3% | at low |
| alltime | all time | -98.0% | +56.8% | -97.2% | at low |
T2 Biosystems Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.08 M(-50.9%) |
| Jun 2024 | - | $4.25 M(-31.6%) |
| Mar 2024 | - | $6.21 M(-60.4%) |
| Dec 2023 | $15.69 M(+51.9%) | $15.69 M(-35.5%) |
| Sep 2023 | - | $24.32 M(+51.2%) |
| Jun 2023 | - | $16.08 M(+59.0%) |
| Mar 2023 | - | $10.12 M(-2.1%) |
| Dec 2022 | $10.33 M(-53.6%) | $10.33 M(-49.3%) |
| Sep 2022 | - | $20.37 M(+54.1%) |
| Jun 2022 | - | $13.21 M(+40.6%) |
| Mar 2022 | - | $9.40 M(-57.8%) |
| Dec 2021 | $22.25 M(+32.5%) | $22.25 M(+0.9%) |
| Sep 2021 | - | $22.05 M(-32.6%) |
| Jun 2021 | - | $32.71 M(+205.9%) |
| Mar 2021 | - | $10.69 M(-36.3%) |
| Dec 2020 | $16.79 M(+52.2%) | $16.79 M(-11.9%) |
| Sep 2020 | - | $19.06 M(-28.2%) |
| Jun 2020 | - | $26.55 M(-26.9%) |
| Mar 2020 | - | $36.32 M(+229.2%) |
| Dec 2019 | $11.03 M(-78.3%) | $11.03 M(-31.9%) |
| Sep 2019 | - | $16.21 M(-43.0%) |
| Jun 2019 | - | $28.42 M(-24.0%) |
| Mar 2019 | - | $37.40 M(-26.4%) |
| Dec 2018 | $50.80 M | $50.80 M(-15.6%) |
| Sep 2018 | - | $60.23 M(-14.8%) |
| Jun 2018 | - | $70.71 M(+137.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $29.73 M(-28.9%) |
| Dec 2017 | $41.80 M(-43.1%) | $41.80 M(-21.0%) |
| Sep 2017 | - | $52.90 M(+14.7%) |
| Jun 2017 | - | $46.13 M(-21.6%) |
| Mar 2017 | - | $58.82 M(-20.0%) |
| Dec 2016 | $73.49 M(-0.2%) | $73.49 M(-2.2%) |
| Sep 2016 | - | $75.11 M(+49.6%) |
| Jun 2016 | - | $50.22 M(-15.6%) |
| Mar 2016 | - | $59.52 M(-19.2%) |
| Dec 2015 | $73.66 M(-0.3%) | $73.66 M(+83.6%) |
| Sep 2015 | - | $40.12 M(-24.7%) |
| Jun 2015 | - | $53.29 M(-18.4%) |
| Mar 2015 | - | $65.30 M(-11.6%) |
| Dec 2014 | $73.85 M(-90.8%) | $73.85 M(-2.3%) |
| Sep 2014 | - | $75.59 M(+376.1%) |
| Jun 2014 | - | $15.88 M(-47.6%) |
| Mar 2014 | - | $30.32 M(+0.4%) |
| Dec 2013 | $801.00 M(+24.5%) | $30.20 M |
| Dec 2012 | $643.50 M(-1.7%) | - |
| Dec 2011 | $654.42 M(+87.6%) | - |
| Dec 2010 | $348.92 M(+2088.5%) | - |
| Dec 2009 | $15.94 M(+55.5%) | - |
| Dec 2008 | $10.26 M(-24.9%) | - |
| Dec 2007 | $13.66 M(+36.5%) | - |
| Dec 2006 | $10.01 M(-33.3%) | - |
| Dec 2005 | $14.99 M(+34.9%) | - |
| Dec 2004 | $11.11 M | - |
FAQ
- What is T2 Biosystems annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for T2 Biosystems?
- What is T2 Biosystems annual cash & cash equivalents year-on-year change?
- What is T2 Biosystems quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for T2 Biosystems?
- What is T2 Biosystems quarterly cash and cash equivalents year-on-year change?
What is T2 Biosystems annual cash & cash equivalents?
The current annual cash & cash equivalents of TTOO is $15.69 M
What is the all time high annual cash & cash equivalents for T2 Biosystems?
T2 Biosystems all-time high annual cash & cash equivalents is $801.00 M
What is T2 Biosystems annual cash & cash equivalents year-on-year change?
Over the past year, TTOO annual cash & cash equivalents has changed by +$5.36 M (+51.89%)
What is T2 Biosystems quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TTOO is $2.08 M
What is the all time high quarterly cash and cash equivalents for T2 Biosystems?
T2 Biosystems all-time high quarterly cash and cash equivalents is $75.59 M
What is T2 Biosystems quarterly cash and cash equivalents year-on-year change?
Over the past year, TTOO quarterly cash and cash equivalents has changed by -$13.61 M (-86.72%)